Basophil activation test with Pru p 7 is predictive of clinical severity in peach allergic patients

Rihane Arif‐lusson (1) , C. Klingebiel , A. Poisson , J. Birnbaum (2) , N. Bonardel , V. Liabeuf (3) , G. Liautard , J. Lidholm , J. Vitte (1)

1 MEPHI - Microbes évolution phylogénie et infections
2 Service des maladies respiratoires [CH d'Aix-en-Provence]
3 Service de dermatologie, vénéreologie et cancérologie cutanée [Hôpital de la Timone - APHM]

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Rihane Arif‐lusson, C. Klingebiel, A. Poisson, J. Birnbaum, N. Bonardel, et al.. Basophil activation test with Pru p 7 is predictive of clinical severity in peach allergic patients: Meeting Abstract: PD0298. Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), 2019, Lisbon, Portugal. pp.75. ⟨hal-02479774⟩